Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6

Ana Paula Zen Petisco Fiore, Virginia A. Spencer, Hidetoshi Mori, Hernandes F. Carvalho, Mina J. Bissell, Alexandre Bruni-Cardoso

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Nuclear actin (N-actin) is known to participate in the regulation of gene expression. We showed previously that N-actin levels mediate the growth and quiescence of mouse epithelial cells in response to laminin-111 (LN1), a component of the mammary basement membrane (BM). We know that BM is defective in malignant cells, and we show here that it is the LN1/N-actin pathway that is aberrant in human breast cancer cells, leading to continuous growth. Photobleaching assays revealed that N-actin exit in nonmalignant cells begins as early as 30 min after LN1 treatment. LN1 attenuates the PI3K pathway leading to upregulation of exportin-6 (XPO6) activity and shuttles actin out of the nucleus. Silencing XPO6 prevents quiescence. Malignant cells are impervious to LN1 signaling. These results shed light on the crucial role of LN1 in quiescence and differentiation and how defects in the LN1/PI3K/XPO6/N-actin axis explain the loss of tissue homeostasis and growth control that contributes to malignant progression.

Original languageEnglish (US)
Pages (from-to)2102-2115
Number of pages14
JournalCell Reports
Volume19
Issue number10
DOIs
StatePublished - Jun 6 2017

Fingerprint

Karyopherins
Laminin
Actins
Phosphatidylinositol 3-Kinases
Basement Membrane
Tissue homeostasis
Growth
Photobleaching
Gene Expression Regulation
Gene expression
Assays
Breast
Homeostasis
Up-Regulation
Epithelial Cells
Cells
Breast Neoplasms
Defects

Keywords

  • basement membrane
  • breast cancer
  • exportin-6
  • extracellular matrix
  • laminin-111
  • mammary gland
  • nuclear actin
  • quiescence

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Fiore, A. P. Z. P., Spencer, V. A., Mori, H., Carvalho, H. F., Bissell, M. J., & Bruni-Cardoso, A. (2017). Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6. Cell Reports, 19(10), 2102-2115. https://doi.org/10.1016/j.celrep.2017.05.050

Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6. / Fiore, Ana Paula Zen Petisco; Spencer, Virginia A.; Mori, Hidetoshi; Carvalho, Hernandes F.; Bissell, Mina J.; Bruni-Cardoso, Alexandre.

In: Cell Reports, Vol. 19, No. 10, 06.06.2017, p. 2102-2115.

Research output: Contribution to journalArticle

Fiore, APZP, Spencer, VA, Mori, H, Carvalho, HF, Bissell, MJ & Bruni-Cardoso, A 2017, 'Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6', Cell Reports, vol. 19, no. 10, pp. 2102-2115. https://doi.org/10.1016/j.celrep.2017.05.050
Fiore, Ana Paula Zen Petisco ; Spencer, Virginia A. ; Mori, Hidetoshi ; Carvalho, Hernandes F. ; Bissell, Mina J. ; Bruni-Cardoso, Alexandre. / Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6. In: Cell Reports. 2017 ; Vol. 19, No. 10. pp. 2102-2115.
@article{798f7729eb904dc4bd8cf8a75b48fcac,
title = "Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6",
abstract = "Nuclear actin (N-actin) is known to participate in the regulation of gene expression. We showed previously that N-actin levels mediate the growth and quiescence of mouse epithelial cells in response to laminin-111 (LN1), a component of the mammary basement membrane (BM). We know that BM is defective in malignant cells, and we show here that it is the LN1/N-actin pathway that is aberrant in human breast cancer cells, leading to continuous growth. Photobleaching assays revealed that N-actin exit in nonmalignant cells begins as early as 30 min after LN1 treatment. LN1 attenuates the PI3K pathway leading to upregulation of exportin-6 (XPO6) activity and shuttles actin out of the nucleus. Silencing XPO6 prevents quiescence. Malignant cells are impervious to LN1 signaling. These results shed light on the crucial role of LN1 in quiescence and differentiation and how defects in the LN1/PI3K/XPO6/N-actin axis explain the loss of tissue homeostasis and growth control that contributes to malignant progression.",
keywords = "basement membrane, breast cancer, exportin-6, extracellular matrix, laminin-111, mammary gland, nuclear actin, quiescence",
author = "Fiore, {Ana Paula Zen Petisco} and Spencer, {Virginia A.} and Hidetoshi Mori and Carvalho, {Hernandes F.} and Bissell, {Mina J.} and Alexandre Bruni-Cardoso",
year = "2017",
month = "6",
day = "6",
doi = "10.1016/j.celrep.2017.05.050",
language = "English (US)",
volume = "19",
pages = "2102--2115",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "10",

}

TY - JOUR

T1 - Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6

AU - Fiore, Ana Paula Zen Petisco

AU - Spencer, Virginia A.

AU - Mori, Hidetoshi

AU - Carvalho, Hernandes F.

AU - Bissell, Mina J.

AU - Bruni-Cardoso, Alexandre

PY - 2017/6/6

Y1 - 2017/6/6

N2 - Nuclear actin (N-actin) is known to participate in the regulation of gene expression. We showed previously that N-actin levels mediate the growth and quiescence of mouse epithelial cells in response to laminin-111 (LN1), a component of the mammary basement membrane (BM). We know that BM is defective in malignant cells, and we show here that it is the LN1/N-actin pathway that is aberrant in human breast cancer cells, leading to continuous growth. Photobleaching assays revealed that N-actin exit in nonmalignant cells begins as early as 30 min after LN1 treatment. LN1 attenuates the PI3K pathway leading to upregulation of exportin-6 (XPO6) activity and shuttles actin out of the nucleus. Silencing XPO6 prevents quiescence. Malignant cells are impervious to LN1 signaling. These results shed light on the crucial role of LN1 in quiescence and differentiation and how defects in the LN1/PI3K/XPO6/N-actin axis explain the loss of tissue homeostasis and growth control that contributes to malignant progression.

AB - Nuclear actin (N-actin) is known to participate in the regulation of gene expression. We showed previously that N-actin levels mediate the growth and quiescence of mouse epithelial cells in response to laminin-111 (LN1), a component of the mammary basement membrane (BM). We know that BM is defective in malignant cells, and we show here that it is the LN1/N-actin pathway that is aberrant in human breast cancer cells, leading to continuous growth. Photobleaching assays revealed that N-actin exit in nonmalignant cells begins as early as 30 min after LN1 treatment. LN1 attenuates the PI3K pathway leading to upregulation of exportin-6 (XPO6) activity and shuttles actin out of the nucleus. Silencing XPO6 prevents quiescence. Malignant cells are impervious to LN1 signaling. These results shed light on the crucial role of LN1 in quiescence and differentiation and how defects in the LN1/PI3K/XPO6/N-actin axis explain the loss of tissue homeostasis and growth control that contributes to malignant progression.

KW - basement membrane

KW - breast cancer

KW - exportin-6

KW - extracellular matrix

KW - laminin-111

KW - mammary gland

KW - nuclear actin

KW - quiescence

UR - http://www.scopus.com/inward/record.url?scp=85020312162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020312162&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2017.05.050

DO - 10.1016/j.celrep.2017.05.050

M3 - Article

C2 - 28591581

AN - SCOPUS:85020312162

VL - 19

SP - 2102

EP - 2115

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 10

ER -